Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy.Viruses · 2023
   Review
2. Biotechnologia · 2023
   Article
3. Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study.BMC medicine · 2022
   Article
4. Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.Molecular immunology · 2022
   Article
5. COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study.Frontiers in public health · 2022
   Article
6. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.Journal of medical Internet research · 2021
   Article
7. Controversy surrounding the Sputnik V vaccine.Respiratory medicine · 2021
   Review
8. Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.European journal of obstetrics, gynecology, and reproductive biology · 2021
   Review
9. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.Medicine in drug discovery · 2021
   Review
10. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial.Lancet (London, England) · 2021
    Article

Corrections and comments

• Comment on
  Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.2020
• Erratum issued
  Department of Error.2020

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as